001     268844
005     20240808164612.0
024 7 _ |a pmc:PMC11031496
|2 pmc
024 7 _ |a 10.1007/s00213-024-06539-3
|2 doi
024 7 _ |a pmid:38407638
|2 pmid
024 7 _ |a 0033-3158
|2 ISSN
024 7 _ |a 1432-2072
|2 ISSN
024 7 _ |a altmetric:160100305
|2 altmetric
037 _ _ |a DZNE-2024-00348
041 _ _ |a English
082 _ _ |a 004
100 1 _ |a Joue, Gina
|b 0
245 _ _ |a Effects of estrogen on spatial navigation and memory.
260 _ _ |a New York, NY
|c 2024
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1713796734_6655
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Animal studies suggest that the so-called 'female' hormone estrogen enhances spatial navigation and memory. This contradicts the observation that males generally out-perform females in spatial navigation and tasks involving spatial memory. A closer look at the vast number of studies actually reveals that performance differences are not so clear.To help clarify the unclear performance differences between men and women and the role of estrogen, we attempted to isolate organizational from activational effects of estrogen on spatial navigation and memory.In a double-blind, placebo-controlled study, we tested the effects of orally administered estradiol valerate (E2V) in healthy, young women in their low-hormone menstrual cycle phase, compared to healthy, young men. Participants performed several first-person, environmentally rich, 3-D computer games inspired by spatial navigation and memory paradigms in animal research.We found navigation behavior suggesting that sex effects dominated any E2 effects with men performing better with allocentric strategies and women with egocentric strategies. Increased E2 levels did not lead to general improvements in spatial ability in either sex but to behavioral changes reflecting navigation flexibility.Estrogen-driven differences in spatial cognition might be better characterized on a spectrum of navigation flexibility rather than by categorical performance measures or skills.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Estradiol: pharmacology
|2 MeSH
650 _ 2 |a Estrogens: pharmacology
|2 MeSH
650 _ 2 |a Spatial Memory
|2 MeSH
650 _ 2 |a Spatial Navigation
|2 MeSH
650 _ 2 |a Double-Blind Method
|2 MeSH
650 _ 7 |a Estradiol
|0 4TI98Z838E
|2 NLM Chemicals
650 _ 7 |a Estrogen
|2 Other
650 _ 7 |a Gender differences
|2 Other
650 _ 7 |a Sex differences
|2 Other
650 _ 7 |a Spatial memory
|2 Other
650 _ 7 |a Spatial navigation
|2 Other
650 _ 7 |a Estrogens
|2 NLM Chemicals
700 1 _ |a Navarro-Schröder, Tobias
|b 1
700 1 _ |a Achtzehn, Johannes
|0 P:(DE-2719)2810753
|b 2
700 1 _ |a Moffat, Scott
|b 3
700 1 _ |a Hennies, Nora
|b 4
700 1 _ |a Fuß, Johannes
|b 5
700 1 _ |a Döller, Christian
|b 6
700 1 _ |a Wolbers, Thomas
|0 P:(DE-2719)2810583
|b 7
700 1 _ |a Sommer, Tobias
|b 8
773 _ _ |a 10.1007/s00213-024-06539-3
|0 PERI:(DE-600)2066933-1
|n 5
|p 1037 - 1063
|t Psychopharmacology
|v 241
|y 2024
|x 0033-3158
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/268844/files/DZNE-2024-00348.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/268844/files/DZNE-2024-00348.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:268844
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2810583
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-24
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PSYCHOPHARMACOLOGY : 2022
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-24
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-24
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2023-10-24
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-24
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-24
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-24
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-24
920 1 _ |0 I:(DE-2719)1310002
|k AG Wolbers
|l Aging, Cognition and Technology
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1310002
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21